相似文献
1
Glucosidase-beta variations and Lewy body disorders.
Parkinsonism Relat Disord. 2009 Jul;15(6):414-6. doi: 10.1016/j.parkreldis.2008.08.004. Epub 2008 Oct 1.
2
A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease.
J Neural Transm (Vienna). 2009 May;116(5):599-605. doi: 10.1007/s00702-009-0209-x. Epub 2009 Apr 2.
3
Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies.
Neurobiol Dis. 2016 Oct;94:55-62. doi: 10.1016/j.nbd.2016.06.004. Epub 2016 Jun 14.
4
A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease.
Arch Neurol. 2003 May;60(5):722-5. doi: 10.1001/archneur.60.5.722.
5
Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease.
PLoS One. 2015 May 1;10(5):e0125204. doi: 10.1371/journal.pone.0125204. eCollection 2015.
6
Association of glucocerebrosidase mutations with dementia with lewy bodies.
Arch Neurol. 2009 May;66(5):578-83. doi: 10.1001/archneurol.2009.54.
7
Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course.
Mov Disord. 2012 Mar;27(3):393-9. doi: 10.1002/mds.24045. Epub 2011 Dec 15.
8
Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy.
Acta Neuropathol Commun. 2020 Oct 22;8(1):172. doi: 10.1186/s40478-020-01050-0.
9
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.
Lancet Neurol. 2018 Jul;17(7):597-608. doi: 10.1016/S1474-4422(18)30179-0. Epub 2018 Jun 7.
10
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
JAMA Neurol. 2013 Jun;70(6):727-35. doi: 10.1001/jamaneurol.2013.1925.
引用本文的文献
1
Peripheral cutaneous synucleinopathy characteristics in genetic Parkinson's disease.
Front Neurol. 2024 May 1;15:1404492. doi: 10.3389/fneur.2024.1404492. eCollection 2024.
2
Effect of GBA gene variants on clinical characteristics of dementia with Lewy bodies: a review and meta-analyses.
Neurol Sci. 2022 Jun;43(6):3541-3550. doi: 10.1007/s10072-022-06031-w. Epub 2022 Mar 24.
3
Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease.
Front Neurol. 2021 Jun 4;12:679927. doi: 10.3389/fneur.2021.679927. eCollection 2021.
4
Fabry Disease With Concomitant Lewy Body Disease.
J Neuropathol Exp Neurol. 2020 Apr 1;79(4):378-392. doi: 10.1093/jnen/nlz139.
5
LRRK2 links genetic and sporadic Parkinson's disease.
Biochem Soc Trans. 2019 Apr 30;47(2):651-661. doi: 10.1042/BST20180462. Epub 2019 Mar 5.
6
Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.
Mov Disord. 2017 Nov;32(11):1504-1523. doi: 10.1002/mds.27193.
7
Mutations in the glucocerebrosidase gene are responsible for Chinese patients with Parkinson's disease.
J Hum Genet. 2015 Feb;60(2):85-90. doi: 10.1038/jhg.2014.110. Epub 2014 Dec 18.
8
Genetic convergence of Parkinson's disease and lysosomal storage disorders.
Mol Neurobiol. 2015;51(3):1554-68. doi: 10.1007/s12035-014-8832-4. Epub 2014 Aug 7.
9
The function of α-synuclein.
Neuron. 2013 Sep 18;79(6):1044-66. doi: 10.1016/j.neuron.2013.09.004.
10
Advances in the genetics of Parkinson disease.
Nat Rev Neurol. 2013 Aug;9(8):445-54. doi: 10.1038/nrneurol.2013.132. Epub 2013 Jul 16.
本文引用的文献
1
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.
Neurology. 2008 Jun 10;70(24):2277-83. doi: 10.1212/01.wnl.0000304039.11891.29. Epub 2008 Apr 23.
2
Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.
Arch Neurol. 2008 Mar;65(3):379-82. doi: 10.1001/archneurol.2007.68.
3
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
Neurology. 2007 Sep 18;69(12):1270-7. doi: 10.1212/01.wnl.0000276989.17578.02.
4
Gaucher disease and the synucleinopathies.
J Biomed Biotechnol. 2006;2006(3):78549. doi: 10.1155/JBB/2006/78549.
5
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.
Neurology. 2006 Sep 12;67(5):908-10. doi: 10.1212/01.wnl.0000230215.41296.18. Epub 2006 Jun 21.
6
Genetics of Parkinson disease: paradigm shifts and future prospects.
Nat Rev Genet. 2006 Apr;7(4):306-18. doi: 10.1038/nrg1831.
7
Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population.
Neurology. 2006 Feb 14;66(3):415-7. doi: 10.1212/01.wnl.0000196492.80676.7c.
8
Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela.
Mov Disord. 2006 Feb;21(2):282-3. doi: 10.1002/mds.20766.
9
Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
N Engl J Med. 2004 Nov 4;351(19):1972-7. doi: 10.1056/NEJMoa033277.
10
Analysis of the glucocerebrosidase gene in Parkinson's disease.
Mov Disord. 2005 Mar;20(3):367-70. doi: 10.1002/mds.20319.
Zotero 插件